Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12145
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSakaguchi, K-
dc.contributor.authorJackson, B-
dc.contributor.authorChai, Syn Y-
dc.contributor.authorMendelsohn, Frederick AO-
dc.contributor.authorJohnson, C I-
dc.date.accessioned2015-05-16T01:47:44Z
dc.date.available2015-05-16T01:47:44Z
dc.date.issued1988-12-01-
dc.identifier.citationJournal of Cardiovascular Pharmacology; 12(6): 710-7en_US
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/12145en
dc.description.abstractInhibition of plasma angiotensin II generation does not fully explain the chronic hypotensive effects of angiotensin-converting enzyme (ACE) inhibitors. Therefore, the pattern of tissue ACE inhibition in rats was studied after oral administration of perindopril, a new ACE inhibitor. Tissue ACE was measured by quantitative in vitro autoradiography using [125I]-351A as a radioligand and compared with plasma ACE and the pressor response to intravenous (i.v.) angiotensin I. Following oral perindopril (1 mg/kg), plasma ACE activity was acutely reduced, but recovered over 24 h. The peak concentration of plasma perindoprilic acid, the active diacid of perindopril, occurred at 1 h, and the drug was undetectable by 24 h. The pressor response to i.v. angiotensin I was inhibited by 95% at 4 h and had not fully recovered by 24 h. Four hours after oral administration of perindopril, ACE was markedly inhibited in the proximal tubules of the kidney (24% control), lung parenchyma (10%), and aortic wall (18%) (p less than 0.01). At 24 h, ACE in these tissues had only partially recovered (32-63%). ACE was also identified in vascular endothelium of organs, including the lung, kidney, and testis; in these sites, vascular ACE showed a pattern of inhibition similar to that of aortic ACE. In contrast, ACE in testicular seminiferous tubules was unaffected by perindopril. These results demonstrate a prolonged effect of ACE inhibitors on tissue ACE that may better explain the time course of these drugs than the changes in plasma ACE or plasma levels of the drug.en_US
dc.language.isoenen
dc.subject.otherAngiotensin I.pharmacologyen
dc.subject.otherAngiotensin II.pharmacologyen
dc.subject.otherAngiotensin-Converting Enzyme Inhibitors.blood.pharmacologyen
dc.subject.otherAnimalsen
dc.subject.otherAorta, Thoracic.enzymologyen
dc.subject.otherAutoradiographyen
dc.subject.otherBlood Pressure.drug effectsen
dc.subject.otherIndoles.blood.pharmacologyen
dc.subject.otherKidney.enzymologyen
dc.subject.otherLung.enzymologyen
dc.subject.otherMaleen
dc.subject.otherPeptidyl-Dipeptidase A.metabolismen
dc.subject.otherPerindoprilen
dc.subject.otherRatsen
dc.subject.otherRats, Inbred Strainsen
dc.subject.otherTestis.enzymologyen
dc.subject.otherTime Factorsen
dc.titleEffects of perindopril on tissue angiotensin-converting enzyme activity demonstrated by quantitative in vitro autoradiography.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleJournal of Cardiovascular Pharmacologyen_US
dc.identifier.affiliationMedicine (University of Melbourne)en_US
dc.description.pages710-7en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/2467090en
dc.type.contentTexten_US
dc.type.austinJournal Articleen
local.name.researcherJackson, Belinda D
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptGastroenterology and Hepatology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

30
checked on Feb 5, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.